Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: A 3-year placebo-controlled biopsy study☆
References (16)
- et al.
Development of glomerular lesions in experimental long-term diabetes in the rat
Kidney Int
(1982) - et al.
Estimation of mean glomerular volume in patients with insulin-dependent diabetes mellitus
Kidney Int
(1987) - et al.
Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria
Kidney Int
(1992) - et al.
Beneficial effect of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy
BMJ
(1986) - et al.
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy
BMJ
(1986) - et al.
The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
N Engl J Med
(1993) - et al.
Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non—insulin-dependent diabetes mellitus
Arch Intern Med
(1996) - et al.
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
J Clin Invest
(1986)
Cited by (56)
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
2021, Kidney InternationalKDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
2020, Kidney InternationalExploring the binding interaction between bovine serum albumin and perindopril as well as influence of metal ions using multi-spectroscopic, molecular docking and DFT calculation
2020, Chemical PhysicsCitation Excerpt :Perindopril have the characteristics of high trough-to-peak ratio (T/P), clinically effective, and weak adverse reactions in ACEIs. Some clinical trials also showed perindopril can reduce left ventricular hypertrophy and proteinuria in diabetic renal dysfunction, and improves arterial structure and function [17]. As far as we know, the study of the binding behavior of perindopril to SA has not been reported yet.
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients with CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials
2016, American Journal of Kidney DiseasesCitation Excerpt :Table 1 summarizes characteristics of the included studies. There were 34 trials that compared ACE inhibitors to placebo,4-6,20-50 7 studies that compared ARBs to placebo,7,51-56 38 studies that compared ACE inhibitors with active controls,12,57-93 and 13 studies that compared ARBs with active controls.94-106 One study compared either ACE inhibitors or ARBs to active control,107 and 1 study compared ACE inhibitors with any antihypertensive treatment.108
Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial
2013, Diabetes Research and Clinical PracticeCitation Excerpt :This a priori designed compliance ancillary study to the RASS provided an opportunity, in a primary prevention trial, to examine adherence patterns over time, including quantification of medication compliance, adherence to interval protocol tasks, as well as submission to the performance of a repeat renal biopsy. Whereas studies of participants with clinical renal disease have included repeated renal biopsies [28–31], to our knowledge this is the first native kidney sequential biopsy primary prevention trial with renal-asymptomatic diabetic participants. This approach was undertaken to study whether the investigational treatments could attenuate morphological changes associated with very early pathological disease progression.
Diabetic nephropathy
2008, Molecular and Genetic Basis of Renal Disease
- ☆
Supported by Servier Laboratories Australia.